ETFRF1: A Potential Drug Target for Various Diseases (G144363)

Target Name: ETFRF1

NCBI ID: G144363

ETFRF1

ETFRF1: A Potential Drug Target for Various Diseases

Electron transfer flavoprotein regulatory factor 1 (ETFFRF1) is a protein that plays a crucial role in the regulation of electron transfer in the cell. It is a member of the superfamily of NAD+-dependent enzymes, known as the flavoprotein gene family 1 (FGF1) . ETFRF1 is widely expressed in various tissues and cells, including muscle, heart, liver, and brain, and is involved in a wide range of cellular processes, including metabolism, cell signaling, and inflammation.

In addition to its role in cellular metabolism, ETFRF1 is also a potential drug target and biomarker. Its involvement in the regulation of electron transfer has led to the development of new therapeutic strategies for a variety of diseases, including cancer, neurodegenerative diseases, and metabolism disorders.

The discovery and characterization of ETFRF1

The study of ETFRF1 began in the late 1980s, when researchers identified a gene that was highly expressed in muscle cells of the mouse. They found that the gene was involved in the regulation of the electron transfer in muscle cells, and that it was encoded by a single exon. This gene was later named ETFRF1, and it has since become the focus of extensive research.

Since its discovery, ETFRF1 has been shown to play a critical role in a wide range of cellular processes. It is involved in the regulation of electron transfer in the cell, which is essential for the proper functioning of many cellular processes, including metabolism, cell signaling, and DNA replication.

In addition to its role in cell signaling, ETFRF1 is also involved in the regulation of cellular processes that are critical for the development and maintenance of tissues. For example, it has been shown to play a role in the regulation of muscle growth and maintenance, and in the development of cancer.

The therapeutic potential uses of ETFRF1

The discovery of ETFRF1 has led to the development of new therapeutic strategies for a variety of diseases. One of the most promising areas of research is the use of ETFRF1 as a drug target.

The development of ETFRF1 as a drug target began with the identification of its involvement in the regulation of cell signaling. ETFRF1 is known to play a role in the regulation of several signaling pathways, including the TGF-β pathway and the Wnt pathway. These signaling pathways are involved in the regulation of cellular processes that are critical for the development and maintenance of tissues, and are potential targets for new therapeutic strategies.

In addition to its involvement in cell signaling, ETFRF1 is also involved in the regulation of cellular processes that are critical for the development and maintenance of tissues. For example, it has been shown to play a role in the regulation of muscle growth and maintenance, and in the development of cancer.

The use of ETFRF1 as a drug target is an exciting area of 鈥嬧?媟esearch, with potential applications in a variety of diseases. One of the most promising strategies for the use of ETFRF1 as a drug target is the use of small molecules to inhibit its activity. This approach has been shown to be effective in the regulation of several cellular processes, including cell signaling and the regulation of muscle growth and maintenance.

In addition to the use of small molecules, another potential strategy for the use of ETFRF1 as a drug target is the use of antibodies to block its activity. This approach has been shown to be effective in the regulation of several cellular processes, including cell signaling and the regulation of muscle growth and maintenance.

The potential applications of ETFRF1 as a drug target are vast and varied. Its involvement in the regulation of cell signaling and cellular processes that are critical for the development and maintenance of tissues makes it an attractive target for the development of new therapeutic strategies for a

Protein Name: Electron Transfer Flavoprotein Regulatory Factor 1

Functions: Acts as a regulator of the electron transfer flavoprotein by promoting the removal of flavin from the ETF holoenzyme (composed of ETFA and ETFB)

The "ETFRF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ETFRF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets